Leveraging the replication stress response to optimize cancer therapy

E Cybulla, A Vindigni - Nature Reviews Cancer, 2023 - nature.com
High-fidelity DNA replication is critical for the faithful transmission of genetic information to
daughter cells. Following genotoxic stress, specialized DNA damage tolerance pathways …

BRCAness, DNA gaps, and gain and loss of PARP inhibitor–induced synthetic lethality

X Li, L Zou - The Journal of Clinical Investigation, 2024 - jci.org
Mutations in the tumor-suppressor genes BRCA1 and BRCA2 resulting in BRCA1/2
deficiency are frequently identified in breast, ovarian, prostate, pancreatic, and other …

Synthetic and medicinal chemistry approaches toward WEE1 kinase inhibitors and its degraders

VJ Alli, P Yadav, V Suresh, SS Jadav - ACS omega, 2023 - ACS Publications
WEE1 is a checkpoint kinase critical for mitotic events, especially in cell maturation and DNA
repair. Most cancer cells' progression and survival are linked with elevated levels of WEE1 …

Paradoxical activation of oncogenic signaling as a cancer treatment strategy

MH Dias, A Friskes, S Wang, JM Fernandes Neto… - Cancer Discovery, 2024 - AACR
Cancer homeostasis depends on a balance between activated oncogenic pathways driving
tumorigenesis and engagement of stress response programs that counteract the inherent …

High-throughput drug screening of primary tumor cells identifies therapeutic strategies for treating children with high-risk cancer

C Mayoh, J Mao, J Xie, G Tax, SO Chow, R Cadiz… - Cancer Research, 2023 - AACR
For one-third of patients with pediatric cancer enrolled in precision medicine programs,
molecular profiling does not result in a therapeutic recommendation. To identify potential …

[HTML][HTML] Inhibitors of the tyrosine kinases FMS-like tyrosine kinase-3 and WEE1 induce apoptosis and DNA damage synergistically in acute myeloid leukemia cells

C Hieber, AHM Mustafa, S Neuroth, S Henninger… - Biomedicine & …, 2024 - Elsevier
Hyperactive FMS-like receptor tyrosine kinase-3 mutants with internal tandem duplications
(FLT3-ITD) are frequent driver mutations of aggressive acute myeloid leukemia (AML) …

Advances in molecular targeted therapies to increase efficacy of (chemo) radiation therapy

K Viktorsson, T Rieckmann, M Fleischmann… - Strahlentherapie und …, 2023 - Springer
Recent advances in understanding the tumor's biology in line with a constantly growing
number of innovative technologies have prompted characterization of patients' individual …

Key Proteins of Replication Stress Response and Cell Cycle Control as Cancer Therapy Targets

AI Khamidullina, YE Abramenko, AV Bruter… - International Journal of …, 2024 - mdpi.com
Replication stress (RS) is a characteristic state of cancer cells as they tend to exchange
precision of replication for fast proliferation and increased genomic instability. To overcome …

Integrated drug profiling and CRISPR screening identify BCR:: ABL1-independent vulnerabilities in chronic myeloid leukemia

SA Awad, O Dufva, J Klievink, E Karjalainen… - Cell Reports …, 2024 - cell.com
Summary BCR:: ABL1-independent pathways contribute to primary resistance to tyrosine
kinase inhibitor (TKI) treatment in chronic myeloid leukemia (CML) and play a role in …

Comprehensive multi-omics analysis reveals WEE1 as a synergistic lethal target with hyperthermia through CDK1 super-activation

X Yang, X Hu, J Yin, W Li, Y Fu, B Yang, J Fan… - Nature …, 2024 - nature.com
Hyperthermic intraperitoneal chemotherapy's role in ovarian cancer remains controversial,
hindered by limited understanding of hyperthermia-induced tumor cellular changes. This …